|
Rimonabant is an anorectic anti-obesity drug. It is a CB1 cannabinoid receptor antagonist. Its main avenue of effect is reduction in appetite. Rimonabant is the first selective CB1 receptor blocker to be approved for use anywhere in the world. |
View the Top Clips from September 23, 2007
Embed This Clip In Your Site...
|
|
|
|